HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
HCA Healthcare Trading Down 0.7 %
Shares of HCA Healthcare stock opened at $342.96 on Friday. HCA Healthcare, Inc. has a 1-year low of $238.82 and a 1-year high of $417.14. The stock has a market cap of $86.87 billion, a P/E ratio of 15.40, a P/E/G ratio of 1.34 and a beta of 1.68. The stock’s 50 day simple moving average is $385.11 and its 200-day simple moving average is $357.25. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00.
HCA Healthcare Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.77%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.
Institutional Trading of HCA Healthcare
Analysts Set New Price Targets
Several research firms have commented on HCA. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 1st. UBS Group upped their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a report on Wednesday, August 14th. Wells Fargo & Company upped their price target on shares of HCA Healthcare from $395.00 to $400.00 and gave the stock an “equal weight” rating in a report on Wednesday, November 6th. Royal Bank of Canada upped their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. Finally, StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Five analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $385.00.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Further Reading
- Five stocks we like better than HCA Healthcare
- How to Use Stock Screeners to Find Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Why is the Ex-Dividend Date Significant to Investors?
- Time to Load Up on Home Builders?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.